Almi Invest/Innovationsbron, the new lead investor in Episentec, has distributed a press release about their investment.
Allan Asp, Investment Manager at Almi Invest, comments: “We are happy to get this opportunity to invest in Episentec. Episentec has a very strong technological edge, and we are convinced that their Label-Enhanced SPR technology will significantly extend the application landscape of optical biosensors. We also note that the development of biosensor technology historically has a strong tradition in Sweden.”
The link to the complete press release (in Swedish) is found here.